Smartleaf Asset Management’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.64K Hold
28
﹤0.01% 2879
2026
Q1
$2.39K Sell
28
-1
-3% -$103 ﹤0.01% 2911
2025
Q4
$2.76K Buy
+29
New +$2.92K ﹤0.01% 2887
2024
Q4
Sell
-189
Closed -$22.3K 2931
2024
Q3
$22.3K Buy
189
+72
+62% +$6.62K ﹤0.01% 1282
2024
Q2
$9.4K Buy
117
+102
+680% +$9.32K ﹤0.01% 1444
2024
Q1
$1.39K Buy
+15
New +$1.44K ﹤0.01% 1542

Other funds holding BNTX

Smartleaf Asset Management's BNTX Position: Q2 2026 in Review

Smartleaf Asset Management held its BioNTech (BNTX) position steady in Q2 2026 at 28 shares worth $2.64K. The position accounts for ﹤0.01% of the portfolio, ranked #2879.

Smartleaf Asset Management first reported a position in BNTX in Q1 2024 and has held it in 6 quarters since. The position peaked at $22.3K in Q3 2024. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Smartleaf Asset Management held 28 shares of BioNTech worth $2.64K as of Q2 2026.
  • Smartleaf Asset Management left its BioNTech share count unchanged in Q2 2026.
  • BioNTech made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2879 holding.
  • Smartleaf Asset Management first reported a position in BioNTech in Q1 2024 and has held it in 6 quarters since.
  • Smartleaf Asset Management's BioNTech position peaked at $22.3K in Q3 2024.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.